This page shows the latest Cavatek news and features for those working in and with pharma, biotech and healthcare.
It will acquire the Australian biotech’s lead cancer therapy Cavatek in the process. ... The pharma group - known as MSD outside the US and Canada - has agreed to buy Australian biotech Viralytics and Cavatek (CVA21), the company’s lead virus-based
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...